DescriptionMind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.
Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.
Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.
Latest Press Releases
|Period||Period Low||Period High||Performance|
|1-Month|| 2.450 +4.49% increase |
| 3.670 -30.25% decrease |
| -0.550 (-17.68%) decrease |
|3-Month|| 2.450 +4.49% increase |
| 3.800 -32.63% decrease |
| -0.970 (-27.48%) decrease |
|52-Week|| 1.930 +32.64% increase |
| 8.000 -68.00% decrease |
| +0.420 (+19.63%) increase |